Coram/CVS Specialty Infusion Goals Q4 14 and Q1 15

• In Q1 2015 after less than 6 months in my current position I have achieved

the following:

• Increased IV Antibiotic referrals from 5 to 9

• Exceeded my Neuromuscular and PID IVIG goals- 133% to goal in Q1 2015

• First Cardiac Inotrope patient to the Tucson branch in 2 years in Q1 2015

• Doubled tube feeding business in Q1 2015

Branch: Branch - Sorted ascendingGoal: Goal Name

Goal Period Sales ID Sales Person Infusion Goal Infusion AdmitsInfusion % to

GoalANT/PAI

GoalANT/PAI Admits

ANT/PAI % to Goal

IGI GoalIGI AdmitsIGI % to

GoalTPN/CRD

GoalTPN/CRD

AdmitsTPN/CRD % to

GoalENT Goal ENT Admits

ENT % to Goal

Branch: Tucson (2 records)42 19 36 14 4 4 2 1 21 9

G-001198 2014Q4 1175Kirsten Caskenette 9 5 56% 7 5 71% 1 0 0% 1 0 0% 9 3 33%

G-001381 2015Q1 1175Kirsten Caskenette 33 14 42% 29 9 31% 3 4 133% 1 1 100% 12 6 50%

Grand Totals (2 records)42 19 36 14 4 4 2 1 21 9

How I created new opportunity at

Coram/CVSReferral Processing Expert:

working Referral with CM or

Medical Office from Start to

Finish

Making Complex referrals

easy by walking physicians

and staff through the

process of how to document

for IVIG Qualification

Novartis team player: Making the El Paso

team the top producer for Ex Patch Speaker

ProgramsCreated easy tools to help

team utilize Technology and

new methods of information

delivery

Novartis- Creating opportunity within a highly

regulated industry by utilizing approved

speaker toolsOnly TM growing new start

business of 4.6 for Ex Patch

EX Patch largest Market

Share change

Novartis showing positive results selling in highly competitive

and generic Market for High Blood Pressure

This increase in Volume, Market Share and Market Share Change was due to strategic

planning to increase call frequency and target past writers that had dropped off use.

Sanofi Aventis Top Performer

Exceeding Goals Process for Success

OrthoBiotech National Ranking #2

125.1% to Goal

2007 Yearly Numbers

Process for using resources

to achieve success.

Darlene Ramsum, B.Sc., Ph.D.

Clinical Affairs Manager, Oncology, West

Ortho Biotech

19 Green Belt Drive

Toronto, Ontario

June 18, 2008

Re: Letter of Recommendation for Kirsten Caskenette

To Whom It May Concern:

This is a formal letter of recommendation for Kirsten Caskenette who was a Product Specialist with the Oncology Division of Ortho Biotech. I had the opportunity to work with Kirsten from March 2005 until January 2008. Kirsten actively pursued training from me on new data and publications. Kirsten showed a very proactive approach to learning and stayed current by engaging me in monthly journal clubs. When working with Kirsten, I always found her knowledgeable, engaging and goal oriented.

I also had the opportunity to work with Kirsten at several CHE events within her territory. Her programs were always well attended and always met the needs of her physicians. Kirsten had very good working relationships with her physicians, which allowed me to gain access and present key clinical data in a timely manner. When working on calls with Kirsten, she consistently demonstrated excellent speaking skills in communicating with a variety of health care professionals at all levels.

As part of Kirsten's knowledge and special skills, she also showed initiative by being the go to person for any database related issues for her team.

I can recommend Kirsten to you without reservation.

If you have any questions, please call me on cell phone at (604) 644-0726.

Sincerely,

Darlene L. Ramsum, PhD